RXO, Inc.
RXO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $3 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $3 | $3 | $4 | $5 |
| Revenue | $1 | $1 | $1 | $2 |
| % Growth | 0.1% | -1% | -14% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 16.6% | 17.9% | 16.2% | 15.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1.4% | 2.8% | 1.5% | 2.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1% | -0.6% | -2.2% | -1.5% |
| EPS Diluted | -0.08 | -0.053 | -0.18 | -0.12 |
| % Growth | -49.8% | 70.3% | -50% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |